Methuselah Foundation - Extending Healthy Human Life
Harvard Scientist Explores:
Longevity, Red Wine & Calorie Restriction

Fifteen years ago David Sinclair moved half way around the world to pursue his interest in longevity. David didn't want to take the usual route, looking for the genes that ended life, he wanted to figure out how to extend it.

Today he strives to devise ways to prevent and treat major diseases by manipulating genes that control how fast we age. David has been a frontrunner in the dramatic shift in research related to the aging process. Ignoring the conventional wisdom that the aging process was too complex to find drugs that could slow it, he works to uncover single genes that could dramatically extend the lifespan of laboratory organisms such as yeast, worms, flies and mice.

This transformation has left us with the fact that the rate of aging is not predetermined - it is naturally regulated by a few critical genes. These genes underlie the remarkable effects of the diet known as calorie restriction (CR), which delays aging in nearly every species tested, from yeast to primates. According to Dr. Sinclair, CR is currently the only treatment that is proven to prevent all diseases of aging including cancer, heart disease, osteoporosis, diabetes and neurodegeneration.

In his own words: "Recent studies in our lab and others demonstrate that the ability of CR to extend lifespan in model organisms is governed by the Sirtuins.* Animals lacking Sirtuin genes do not respond to CR while additional gene copies extend lifespan. Based on these findings, we have engineered small molecules that can activate mammalian Sirtuins in vivo, with a view to developing drugs that can:

1. Treat the diseases of aging and

2. Promote cell survival and recovery following an injury.

We utilize any approach we need to answer a specific question including chemistry, biochemistry, genetics and cell biology. Models systems include yeast, C. elegans, mammalian cell culture and rodents."

Current Work with Resveratol and other SIRT1 Activating Compounds (STACs)

David has been working with Rafael deCabo, National Institute on Aging of the National Institutes on Health, using CR, resveratrol, and molecules 1000 times more potent than resveratrol to delay diseases of aging and extend the healthspan of mice. Resveratol is found in the skin of red grapes. News about the health benefits of red wine, and resveratol, have made headlines in recent years, often related to the work of David's lab. Currently David and Rafa are testing the hypothesis that they will "see significant lifespan extension in mice started on the molecules at a younger age, and using the more potent SIRT1** activators that Sirtris has developed." Sirtris is the company David Sinclair co-founded to explore sirtuin research, it is now owned by GlaxoSmithKline. Sirtris is in clinical trials in 2009 and 2010 to test their potent SIRT1 activators in a variety of diseases of aging including type II diabetes.

A recent article in Cell, co-authored by David Sinclair, postulates that changes in gene expression and chromatin structure might underlie aging. Read it here.

* Sirtuins are a recently discovered family of seven enzymes associated with the aging process.

**SIRT1 is a sirtuin

Featured Testimonial
How many lives will the Methuselah Foundation save? How about at least 66 million? Here's how I estimate that. Current world population of 6.6B. Conservatively assume 1% die each year from aging related causes, so that's 66 million aging driven deaths per year. Accelerate the date by which aging ceases to be a routine cause of death by just a single year, and 66 million lives will have been saved.
We think such a one year acceleration is a modest goal for the Foundation. If it stimulates a 10 year acceleration, that would mean 660 million lives saved! We want to help the Foundation do that, and to be there to enjoy the results.
The Shapard Family
Thomas Shapard, Joanne Shapard, and Catherine Phillips

Read More Testimonials

Foundation Profile:
David Sinclair

David A. Sinclair, Ph.D. is the Co-Director of the Paul F. Glenn Laboratories for the Molecular Biology of Aging, an Associate Professor of Pathology at Harvard Medical School, Associate Member of the Broad Institute for Systems Biology, co-founder of Sirtris Pharma-ceuticals and a competitor for the MPrize.  A native of St. Ives Australia, in 1995 he joined Leonard P. Guarente (another MPrize competitor) at MIT to pursue his interest in longevity and aging.  He has been at Harvard since 1999.

Read More About David and His Work

Join The

Last call!  This special group of donors has responded to the  challenge to contribute $1000 a year for 25 years.  Fill one of the few remaining slots and your donation will go to work immediately funding innovative technology that will change science forever.  
As a 300 member you'll get advance notice of news and events, have the opportunity to participate in exclusive webinars, receive a monthly email from Dave Gobel and have the satisfaction of knowing your gift will result in extended healthy life for yourself, your family and all humanity. 
More news on The 300 monument coming soon – join now and have your name and message included.

Special $500 MFoundation Discount
TEDMED has generously offered a special $500 discount for all Methuselah Foundation members!
The conference where “healthcare and medicine collide with brilliant minds and uninhibited imagination” will be held October 27-30 in San Diego, California.  Enter the code mfoundation under Group Code on the registration page to receive your discount.  The conference is expected to sell out soon so don’t wait.